Axial Spondyloarthritis

🌍 Did you know that only four African countries have updated their National Essential Medicines Lists since 2021 to include modern treatments for rheumatic diseases in children? This gap highlights the urgent need for policy development and innovative financing strategies. Let's work together to ensure every child has access to the medicines they need. #SyenzaNews #Healthcare #RheumaticDiseases #EssentialMedicines #UniversalHealthCoverage 📢 Learn more about how we can improve access to essential medicines for children with rheumatic diseases in Africa. Read our latest article!

🌟 #SyenzaNews 🌟 Discover how PAFLAR is advancing paediatric rheumatology care in Africa! From empowering Therapeutic Patient Education workshops to inspiring stories of dedicated professionals, learn about the strides being made to improve the lives of children with rheumatic diseases. 🌍👩‍⚕️👨‍⚕️ #PaediatricRheumatology #HealthcareInnovation #PatientEducation #MedicalAdvocacy #GlobalHealth #JIA 🩺 Together, we can make a difference!

🌟Enhancing Early Diagnosis and Access to Care for Juvenile Idiopathic Arthritis 🌟 Delays in diagnosing and treating juvenile idiopathic arthritis (JIA) can significantly impact the quality of life for children and young people. Our latest article explores the factors contributing to these delays and suggests strategies to facilitate earlier diagnosis and prompt referral to paediatric rheumatology care. Learn more about how education, awareness, and streamlined referral pathways can improve outcomes for CYP with JIA. Read the full article here #SyenzaNews #JuvenileArthritis #Healthcare #PaediatricRheumatology #EarlyDiagnosis #PatientCare

🌟 Exciting advancements in #Healthcare! Researchers at Washington University have developed a new AI-driven method to predict surgical recovery outcomes more accurately. By integrating data from wearable devices and longitudinal assessments, this approach offers a comprehensive view of patient recovery. Discover how this innovation is transforming patient care. #AIinHealthcare #SurgicalRecovery #WearableTechnology #MachineLearning #PatientCare

Discover a new cost-effective approach to managing fatigue in Inflammatory Rheumatic Diseases. Our latest article reveals the economic and health benefits of personalised exercise programmes. Read more here 👉 #Healthcare #RheumaticDiseases #FatigueManagement

Explore the key takeaways from the CHMP February 2024 meeting. From new vaccines to innovative disease treatments, the future of healthcare is promising. Read our latest article to learn more. #CHMP2024 #HealthcareInnovation #NewDrugApprovals 🏥🔬🧬

Juvenile Idiopathic Arthritis (JIA) is an autoimmune disease where the body’s immune system mistakenly attacks its own healthy cells and tissues, leading to inflammation in the joint membrane or the synovial membrane. This condition is the most prevalent type of arthritis in children under the age of 16. JIA is included in the Chronic Disease List (CDL) of the Prescribed Minimum Benefit (PMB) regulations under Rheumatoid Arthritis in South Africa. This means that medical schemes are obligated to fully fund […]

Treatment guidelines for adults with active non-radiographic axial spondyloarthritis recommend the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Tumor Necrosis Factor-alpha (TNF-alpha) inhibitors. If these first-line treatments don’t work or aren’t suitable, doctors may consider secukinumab or ixekizumab (IL-17 inhibitors). Clinical trials show that upadacitinib, an oral Janus Kinase (JAK) inhibitor, can reduce symptoms and improve the quality of life in Spondyloarthritis (SpA) patients. This effectiveness rivals that of biologics. Clinicians use the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) […]